<SEC-DOCUMENT>0001193125-21-206765-index.html : 20210702
<SEC-HEADER>0001193125-21-206765.hdr.sgml : 20210702
<ACCEPTANCE-DATETIME>20210701213117
ACCESSION NUMBER:		0001193125-21-206765
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20210702
DATE AS OF CHANGE:		20210701
EFFECTIVENESS DATE:		20210702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxcyte, Inc.
		CENTRAL INDEX KEY:			0001649094
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				464233385
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-257622
		FILM NUMBER:		211067842

	BUSINESS ADDRESS:	
		STREET 1:		353 HATCH DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-837-0111

	MAIL ADDRESS:	
		STREET 1:		353 HATCH DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SutroVax, Inc.
		DATE OF NAME CHANGE:	20150724
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d63337ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
Document 1 - file: d63337ds3asr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>d63337dex12.htm
<DESCRIPTION>EX-1.2
<TEXT>
Document 2 - file: d63337dex12.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>d63337dex44.htm
<DESCRIPTION>EX-4.4
<TEXT>
Document 3 - file: d63337dex44.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d63337dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 4 - file: d63337dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>d63337dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 5 - file: d63337dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g63337g56f90.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g63337g56f90.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g63337hj06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: g63337hj06.jpg

</DOCUMENT>
</SEC-DOCUMENT>